Edition:
India

People: TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

5.52USD
20 Mar 2019
Change (% chg)

-- (--)
Prev Close
$5.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
734,700
52-wk High
$7.66
52-wk Low
$3.51

Finizio, Robert 

Mr. Robert G. Finizio is Chief Executive Officer, Director of TherapeuticsMD, Inc. As co-founder of VitaMedMD, LLC, or VitaMed, our wholly owned subsidiary, he served as its Chief Executive Officer and a director from April 2008 to October 2011. Mr. Finizio has 16 years of successful early stage company development experience in the health care industry. Mr. Finizio co-founded and served from August 2001 to February 2008 as President of Care Fusion, LLC and then as Chief Executive Officer of CareFusion, Inc., a clinical technology vendor, which was acquired by Cardinal Health, Inc. Mr. Finizio’s early business experience was with Omnicell, Inc. (formerly known as Omnicell Technologies, Inc.), a provider of pharmaceutical supply chain management systems and services, and Endoscopy Specialists, Inc. in the health care IT and surgical space. We believe Mr. Finizio’s intimate knowledge and experience with all aspects of the business, operations, opportunities, and challenges of our company and experience with early stage company development in the health care industry provide the requisite qualifications, skills, perspectives, and experience that make him well qualified to serve on our Board of Directors. Mr. Finizio earned a B.A. from the University of Miami.

Basic Compensation

Total Annual Compensation, USD 640,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,343,960
Fiscal Year Total, USD 2,983,960

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 31,526 25,221.00
Name Fiscal Year Total

Tommy Thompson

363,423

John Milligan

1,840,030

Robert Finizio

2,983,960

Daniel Cartwright

1,352,780

Mitchell Krassan

1,221,410

Michael Donegan

531,491
As Of  31 Dec 2017